chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 101 Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (101 Fever) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced PYREXIA (101 Fever). At the time of the report, PYREXIA (101 Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication provided by Reporter.  No treatment information provided by Reporter.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Vaccination site lymphadenopathy
Clinical narrative: chills in my left and right arms; lymph nodes in injection site arm feel painful; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills in my left and right arms) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes in injection site arm feel painful) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced CHILLS (chills in my left and right arms) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes in injection site arm feel painful). At the time of the report, CHILLS (chills in my left and right arms) and VACCINATION SITE LYMPHADENOPATHY (lymph nodes in injection site arm feel painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment medications were provided
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Intentional product use issue
Clinical narrative: Missed 2 appointments/ delayed 2nd shot of Moderna Covid-19 vaccine beyond 42 days; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (Missed 2 appointments/ delayed 2nd shot of Moderna Covid-19 vaccine beyond 42 days) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Missed 2 appointments/ delayed 2nd shot of Moderna Covid-19 vaccine beyond 42 days). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (Missed 2 appointments/ delayed 2nd shot of Moderna Covid-19 vaccine beyond 42 days) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Patient wanted to know Can he take the 2nd dose?   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up was received on 16-JUN-2021. It contains no new information.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dyskinesia, Energy increased, Feeling jittery, Hypervigilance
Clinical narrative: very alert; confused; jittery; always moving; only slept in 2-3 hour intervals; hyper; This spontaneous case was reported by a consumer and describes the occurrence of HYPERVIGILANCE (very alert), CONFUSIONAL STATE (confused), FEELING JITTERY (jittery), DYSKINESIA (always moving) and SLEEP DISORDER (only slept in 2-3 hour intervals) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced HYPERVIGILANCE (very alert), CONFUSIONAL STATE (confused), FEELING JITTERY (jittery), DYSKINESIA (always moving), SLEEP DISORDER (only slept in 2-3 hour intervals) and ENERGY INCREASED (hyper). At the time of the report, HYPERVIGILANCE (very alert), CONFUSIONAL STATE (confused), FEELING JITTERY (jittery), DYSKINESIA (always moving), SLEEP DISORDER (only slept in 2-3 hour intervals) and ENERGY INCREASED (hyper) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not  consent for safety team to contact her HCP
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: very alert; confused; jittery; always moving; only slept in 2-3 hour intervals; hyper; This spontaneous case was reported by a consumer and describes the occurrence of HYPERVIGILANCE (very alert), CONFUSIONAL STATE (confused), FEELING JITTERY (jittery), DYSKINESIA (always moving) and SLEEP DISORDER (only slept in 2-3 hour intervals) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced HYPERVIGILANCE (very alert), CONFUSIONAL STATE (confused), FEELING JITTERY (jittery), DYSKINESIA (always moving), SLEEP DISORDER (only slept in 2-3 hour intervals) and ENERGY INCREASED (hyper). At the time of the report, HYPERVIGILANCE (very alert), CONFUSIONAL STATE (confused), FEELING JITTERY (jittery), DYSKINESIA (always moving), SLEEP DISORDER (only slept in 2-3 hour intervals) and ENERGY INCREASED (hyper) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not  consent for safety team to contact her HCP
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Vaccination site erythema
Clinical narrative: itchy; pain in the arm, itchy, and red as orange; pain in the arm, itchy, and red as orange; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), PAIN IN EXTREMITY (pain in the arm, itchy, and red as orange) and VACCINATION SITE ERYTHEMA (pain in the arm, itchy, and red as orange) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PRURITUS (itchy), PAIN IN EXTREMITY (pain in the arm, itchy, and red as orange) and VACCINATION SITE ERYTHEMA (pain in the arm, itchy, and red as orange). At the time of the report, PRURITUS (itchy) and PAIN IN EXTREMITY (pain in the arm, itchy, and red as orange) outcome was unknown and VACCINATION SITE ERYTHEMA (pain in the arm, itchy, and red as orange) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient received Meloxicam for Sinux nasal inhaler.   This case was linked to US-MODERNATX, INC.-MOD-2021-068480 (E2B Linked Report). This case was linked to MOD-2021-148532 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Non significant follow up report was received on 19 May 2021.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068480:
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia, Vaccination site erythema, Vaccination site pain
Clinical narrative: Injection site is red; Injection site swollen; Pain at the injection site; Fever; Big headache; Very Tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Pain at the injection site), PYREXIA (Fever) and HEADACHE (Big headache) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Pain at the injection site), PYREXIA (Fever), HEADACHE (Big headache) and FATIGUE (Very Tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Pain at the injection site), PYREXIA (Fever), HEADACHE (Big headache) and FATIGUE (Very Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient did not take concomitant medication.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Reporter declined consent to follow-up on ADRs.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Injection site is red; Injection site swollen; Pain at the injection site; Fever; Big headache; Very Tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Pain at the injection site), PYREXIA (Fever) and HEADACHE (Big headache) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Pain at the injection site), PYREXIA (Fever), HEADACHE (Big headache) and FATIGUE (Very Tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Pain at the injection site), PYREXIA (Fever), HEADACHE (Big headache) and FATIGUE (Very Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient did not take concomitant medication.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Reporter declined consent to follow-up on ADRs.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Diagnosed with COVID; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Diagnosed with COVID) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Diagnosed with COVID). At the time of the report, COVID-19 (Diagnosed with COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter.  No treatment medication was provided.     Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: TCR-Follow up information received on 18-May-2021 contains no new information; Sender's Comments:
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Feeling hot, Illness, Pain, Pain in extremity
Clinical narrative: feels so sick she wants to die; everything hurts so bad; back is really hurting; she's so hot; shaking so hard; feels really crappy; arm is so sore she can hardly touch it; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (feels so sick she wants to die), PAIN (everything hurts so bad), BACK PAIN (back is really hurting), FEELING HOT (she's so hot) and TREMOR (shaking so hard) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (feels so sick she wants to die), PAIN (everything hurts so bad), BACK PAIN (back is really hurting), FEELING HOT (she's so hot), TREMOR (shaking so hard), PERSONALITY DISORDER (feels really crappy) and PAIN IN EXTREMITY (arm is so sore she can hardly touch it). At the time of the report, ILLNESS (feels so sick she wants to die), PAIN (everything hurts so bad), BACK PAIN (back is really hurting), FEELING HOT (she's so hot), TREMOR (shaking so hard), PERSONALITY DISORDER (feels really crappy) and PAIN IN EXTREMITY (arm is so sore she can hardly touch it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  Treatment products included Tylenol.
Sex: F
Vaccine: COVID19
Symptoms: Personality disorder, Tremor
Clinical narrative: feels so sick she wants to die; everything hurts so bad; back is really hurting; she's so hot; shaking so hard; feels really crappy; arm is so sore she can hardly touch it; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (feels so sick she wants to die), PAIN (everything hurts so bad), BACK PAIN (back is really hurting), FEELING HOT (she's so hot) and TREMOR (shaking so hard) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (feels so sick she wants to die), PAIN (everything hurts so bad), BACK PAIN (back is really hurting), FEELING HOT (she's so hot), TREMOR (shaking so hard), PERSONALITY DISORDER (feels really crappy) and PAIN IN EXTREMITY (arm is so sore she can hardly touch it). At the time of the report, ILLNESS (feels so sick she wants to die), PAIN (everything hurts so bad), BACK PAIN (back is really hurting), FEELING HOT (she's so hot), TREMOR (shaking so hard), PERSONALITY DISORDER (feels really crappy) and PAIN IN EXTREMITY (arm is so sore she can hardly touch it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  Treatment products included Tylenol.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: a pear shaped red sport at the injection; a little bit of soreness at the injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (a little bit of soreness at the injection) and VACCINATION SITE ERYTHEMA (a pear shaped red sport at the injection) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (a little bit of soreness at the injection). On 25-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (a pear shaped red sport at the injection). On 17-Jan-2021, VACCINATION SITE PAIN (a little bit of soreness at the injection) had resolved. On 30-Jan-2021, VACCINATION SITE ERYTHEMA (a pear shaped red sport at the injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. Concomitant medication was not provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Mild arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Mild arm soreness) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included LINACLOTIDE (LINZESS) and LISINOPRIL for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (Mild arm soreness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Mild arm soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-068799 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068799:crosslinked to Dose 2
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Eating disorder, Headache, Hunger, Peripheral swelling, Vaccination site pain
Clinical narrative: swelling at the location of the shot; I had not eaten; swollen arm; hunger; Pain at injection site; headache; This spontaneous case was reported by a nurse and describes the occurrence of PERIPHERAL SWELLING (swollen arm), HUNGER (hunger), VACCINATION SITE PAIN (Pain at injection site), HEADACHE (headache) and VACCINATION SITE SWELLING (swelling at the location of the shot) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Fish allergy, Food allergy (Allergy from strawberry) and Drug allergy.    On 06-Apr-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PERIPHERAL SWELLING (swollen arm) and HUNGER (hunger). 06-Apr-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site) and HEADACHE (headache). On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling at the location of the shot) and EATING DISORDER (I had not eaten). On 10-Apr-2021, PERIPHERAL SWELLING (swollen arm) and HEADACHE (headache) had resolved. At the time of the report, HUNGER (hunger), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE SWELLING (swelling at the location of the shot) and EATING DISORDER (I had not eaten) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided. The first vaccine caused only swelling at the location of the shot. It lasted several days. Consumer called the health line and mentioned a headache but it was because she had not eaten.   This case was linked to MOD-2021-268664 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Significant follow up appended
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: swelling at the location of the shot; I had not eaten; swollen arm; hunger; Pain at injection site; headache; This spontaneous case was reported by a nurse and describes the occurrence of PERIPHERAL SWELLING (swollen arm), HUNGER (hunger), VACCINATION SITE PAIN (Pain at injection site), HEADACHE (headache) and VACCINATION SITE SWELLING (swelling at the location of the shot) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Fish allergy, Food allergy (Allergy from strawberry) and Drug allergy.    On 06-Apr-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PERIPHERAL SWELLING (swollen arm) and HUNGER (hunger). 06-Apr-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site) and HEADACHE (headache). On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling at the location of the shot) and EATING DISORDER (I had not eaten). On 10-Apr-2021, PERIPHERAL SWELLING (swollen arm) and HEADACHE (headache) had resolved. At the time of the report, HUNGER (hunger), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE SWELLING (swelling at the location of the shot) and EATING DISORDER (I had not eaten) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided. The first vaccine caused only swelling at the location of the shot. It lasted several days. Consumer called the health line and mentioned a headache but it was because she had not eaten.   This case was linked to MOD-2021-268664 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Significant follow up appended
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Dizziness, Fatigue
Clinical narrative: felt faint; flu; weak; vomiting; nausea; fever; chills; muscle pain; joint pain; fatigue; site pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt faint), INFLUENZA (flu), ASTHENIA (weak), VOMITING (vomiting) and NAUSEA (nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Apr-2021 at 10:45 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PYREXIA (fever), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (fatigue) and VACCINATION SITE PAIN (site pain at the injection site). On 06-Apr-2021, the patient experienced DIZZINESS (felt faint), INFLUENZA (flu), ASTHENIA (weak), VOMITING (vomiting) and NAUSEA (nausea). At the time of the report, DIZZINESS (felt faint), INFLUENZA (flu), ASTHENIA (weak), VOMITING (vomiting), NAUSEA (nausea), PYREXIA (fever), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (fatigue) and VACCINATION SITE PAIN (site pain at the injection site) outcome was unknown. Not Provided          It was reported that patient's was doing better for the unspecified event.   No concomitant product reported.  No treatment medication specified.   Action taken with mRNA-1273 in response to events was not applicable.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza, Myalgia, Nausea, Pyrexia, Vaccination site pain
Clinical narrative: felt faint; flu; weak; vomiting; nausea; fever; chills; muscle pain; joint pain; fatigue; site pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt faint), INFLUENZA (flu), ASTHENIA (weak), VOMITING (vomiting) and NAUSEA (nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Apr-2021 at 10:45 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PYREXIA (fever), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (fatigue) and VACCINATION SITE PAIN (site pain at the injection site). On 06-Apr-2021, the patient experienced DIZZINESS (felt faint), INFLUENZA (flu), ASTHENIA (weak), VOMITING (vomiting) and NAUSEA (nausea). At the time of the report, DIZZINESS (felt faint), INFLUENZA (flu), ASTHENIA (weak), VOMITING (vomiting), NAUSEA (nausea), PYREXIA (fever), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (fatigue) and VACCINATION SITE PAIN (site pain at the injection site) outcome was unknown. Not Provided          It was reported that patient's was doing better for the unspecified event.   No concomitant product reported.  No treatment medication specified.   Action taken with mRNA-1273 in response to events was not applicable.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: felt faint; flu; weak; vomiting; nausea; fever; chills; muscle pain; joint pain; fatigue; site pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt faint), INFLUENZA (flu), ASTHENIA (weak), VOMITING (vomiting) and NAUSEA (nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Apr-2021 at 10:45 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PYREXIA (fever), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (fatigue) and VACCINATION SITE PAIN (site pain at the injection site). On 06-Apr-2021, the patient experienced DIZZINESS (felt faint), INFLUENZA (flu), ASTHENIA (weak), VOMITING (vomiting) and NAUSEA (nausea). At the time of the report, DIZZINESS (felt faint), INFLUENZA (flu), ASTHENIA (weak), VOMITING (vomiting), NAUSEA (nausea), PYREXIA (fever), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (fatigue) and VACCINATION SITE PAIN (site pain at the injection site) outcome was unknown. Not Provided          It was reported that patient's was doing better for the unspecified event.   No concomitant product reported.  No treatment medication specified.   Action taken with mRNA-1273 in response to events was not applicable.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: mild arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (mild arm soreness) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LINACLOTIDE (LINZESS) and LISINOPRIL for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (mild arm soreness). At the time of the report, VACCINATION SITE PAIN (mild arm soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-068789 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068789:crosslinked to Dose 1
Sex: F
Vaccine: COVID19
Symptoms: Muscle twitching
Clinical narrative: Twitching of nose upper part, eye and toe; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (Twitching of nose upper part, eye and toe) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, the patient experienced MUSCLE TWITCHING (Twitching of nose upper part, eye and toe). At the time of the report, MUSCLE TWITCHING (Twitching of nose upper part, eye and toe) outcome was unknown. Not Provided          Reporter did not allow further contact
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Back pain, Chills, Diarrhoea, Fatigue
Clinical narrative: Insomnia; Fatigue; Nausea; Vomiting; Chills; Headache; Diarrhea; Back Pain; Extreme Stomach Cramps; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Insomnia), ABDOMINAL PAIN UPPER (Extreme Stomach Cramps), DIARRHOEA (Diarrhea), BACK PAIN (Back Pain) and FATIGUE (Fatigue) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Extreme Stomach Cramps). On 02-Apr-2021, the patient experienced DIARRHOEA (Diarrhea), BACK PAIN (Back Pain), NAUSEA (Nausea), VOMITING (Vomiting), CHILLS (Chills) and HEADACHE (Headache). On 04-Apr-2021, the patient experienced INSOMNIA (Insomnia) and FATIGUE (Fatigue). On 04-Apr-2021, ABDOMINAL PAIN UPPER (Extreme Stomach Cramps), DIARRHOEA (Diarrhea) and NAUSEA (Nausea) had resolved. On 05-Apr-2021, BACK PAIN (Back Pain), VOMITING (Vomiting), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, INSOMNIA (Insomnia) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Insomnia, Nausea, Vomiting
Clinical narrative: Insomnia; Fatigue; Nausea; Vomiting; Chills; Headache; Diarrhea; Back Pain; Extreme Stomach Cramps; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Insomnia), ABDOMINAL PAIN UPPER (Extreme Stomach Cramps), DIARRHOEA (Diarrhea), BACK PAIN (Back Pain) and FATIGUE (Fatigue) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Extreme Stomach Cramps). On 02-Apr-2021, the patient experienced DIARRHOEA (Diarrhea), BACK PAIN (Back Pain), NAUSEA (Nausea), VOMITING (Vomiting), CHILLS (Chills) and HEADACHE (Headache). On 04-Apr-2021, the patient experienced INSOMNIA (Insomnia) and FATIGUE (Fatigue). On 04-Apr-2021, ABDOMINAL PAIN UPPER (Extreme Stomach Cramps), DIARRHOEA (Diarrhea) and NAUSEA (Nausea) had resolved. On 05-Apr-2021, BACK PAIN (Back Pain), VOMITING (Vomiting), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, INSOMNIA (Insomnia) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnancy (received vaccine); This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy (received vaccine)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 30-Dec-2020 and the estimated date of delivery was 07-Oct-2021. On 30-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy (received vaccine)). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twelfth week of the pregnancy.  On 30-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy (received vaccine)) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications and treatment medications were reported. Lab tests include Genetic testing.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Product administered to patient of inappropriate age
Clinical narrative: Inappropriate schedule of vaccine administered; 17-year-old patients received the first dose of Moderna COVID-19 vaccine by accident; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old patients received the first dose of Moderna COVID-19 vaccine by accident) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered ) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 038c21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old patients received the first dose of Moderna COVID-19 vaccine by accident). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered ). On 09-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old patients received the first dose of Moderna COVID-19 vaccine by accident) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered ) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow up received on 21-Jun-2021, no new information was recorded On 28-Jun-2021: Second dose details and start date was updated.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose decreased, Feeling jittery, Nervousness
Clinical narrative: feeling very shaky; fells like she has low blood sugar; Feels jittery; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (feeling very shaky), BLOOD GLUCOSE DECREASED (fells like she has low blood sugar) and FEELING JITTERY (Feels jittery) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced NERVOUSNESS (feeling very shaky), BLOOD GLUCOSE DECREASED (fells like she has low blood sugar) and FEELING JITTERY (Feels jittery). At the time of the report, NERVOUSNESS (feeling very shaky), BLOOD GLUCOSE DECREASED (fells like she has low blood sugar) and FEELING JITTERY (Feels jittery) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Paraesthesia, Pyrexia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: arm hot; arm tingling; Arm hard to lift; Arm immediately swelled to the size of a golf ball; arm red; fever; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH (arm hot), PARAESTHESIA (arm tingling), MOBILITY DECREASED (Arm hard to lift), VACCINATION SITE SWELLING (Arm immediately swelled to the size of a golf ball) and VACCINATION SITE ERYTHEMA (arm red) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 01-Apr-2021, the patient experienced VACCINATION SITE WARMTH (arm hot), PARAESTHESIA (arm tingling), MOBILITY DECREASED (Arm hard to lift), VACCINATION SITE SWELLING (Arm immediately swelled to the size of a golf ball), VACCINATION SITE ERYTHEMA (arm red) and PYREXIA (fever). On 03-Apr-2021, PYREXIA (fever) outcome was unknown. At the time of the report, VACCINATION SITE WARMTH (arm hot), PARAESTHESIA (arm tingling), MOBILITY DECREASED (Arm hard to lift), VACCINATION SITE SWELLING (Arm immediately swelled to the size of a golf ball) and VACCINATION SITE ERYTHEMA (arm red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        relevant concomitant products usage were not reported by the reporter. Treatment details not included.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: arm hot; arm tingling; Arm hard to lift; Arm immediately swelled to the size of a golf ball; arm red; fever; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH (arm hot), PARAESTHESIA (arm tingling), MOBILITY DECREASED (Arm hard to lift), VACCINATION SITE SWELLING (Arm immediately swelled to the size of a golf ball) and VACCINATION SITE ERYTHEMA (arm red) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 01-Apr-2021, the patient experienced VACCINATION SITE WARMTH (arm hot), PARAESTHESIA (arm tingling), MOBILITY DECREASED (Arm hard to lift), VACCINATION SITE SWELLING (Arm immediately swelled to the size of a golf ball), VACCINATION SITE ERYTHEMA (arm red) and PYREXIA (fever). On 03-Apr-2021, PYREXIA (fever) outcome was unknown. At the time of the report, VACCINATION SITE WARMTH (arm hot), PARAESTHESIA (arm tingling), MOBILITY DECREASED (Arm hard to lift), VACCINATION SITE SWELLING (Arm immediately swelled to the size of a golf ball) and VACCINATION SITE ERYTHEMA (arm red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        relevant concomitant products usage were not reported by the reporter. Treatment details not included.
Sex: F
Vaccine: COVID19
Symptoms: Shoulder injury related to vaccine administration, Vaccination site movement impairment
Clinical narrative: 2 days afterwards she was unable to lift more than 10 degrees; Believes Vaccine was administered improperly, saying it hit her shoulder; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (Believes Vaccine was administered improperly, saying it hit her shoulder) and VACCINATION SITE MOVEMENT IMPAIRMENT (2 days afterwards she was unable to lift more than 10 degrees) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (Believes Vaccine was administered improperly, saying it hit her shoulder). On 29-Mar-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (2 days afterwards she was unable to lift more than 10 degrees). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form and IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (Believes Vaccine was administered improperly, saying it hit her shoulder) and VACCINATION SITE MOVEMENT IMPAIRMENT (2 days afterwards she was unable to lift more than 10 degrees) outcome was unknown. Not Provided
Sex: U
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Heart rate
Clinical narrative: Fatigue; Chills; Headache; Dizziness; Nausea; Heart rate increased; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), CHILLS (Chills), HEADACHE (Headache), DIZZINESS (Dizziness) and NAUSEA (Nausea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  No concomitant medication reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue), CHILLS (Chills), HEADACHE (Headache), DIZZINESS (Dizziness), NAUSEA (Nausea) and HEART RATE INCREASED (Heart rate increased). At the time of the report, FATIGUE (Fatigue), CHILLS (Chills), HEADACHE (Headache), DIZZINESS (Dizziness), NAUSEA (Nausea) and HEART RATE INCREASED (Heart rate increased) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 163 bpm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported. Treatment details were not reported.
Sex: U
Vaccine: COVID19
Symptoms: Heart rate increased, Nausea
Clinical narrative: Fatigue; Chills; Headache; Dizziness; Nausea; Heart rate increased; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), CHILLS (Chills), HEADACHE (Headache), DIZZINESS (Dizziness) and NAUSEA (Nausea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  No concomitant medication reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue), CHILLS (Chills), HEADACHE (Headache), DIZZINESS (Dizziness), NAUSEA (Nausea) and HEART RATE INCREASED (Heart rate increased). At the time of the report, FATIGUE (Fatigue), CHILLS (Chills), HEADACHE (Headache), DIZZINESS (Dizziness), NAUSEA (Nausea) and HEART RATE INCREASED (Heart rate increased) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 163 bpm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported. Treatment details were not reported.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient got 2nd dose of pfizer instead of Moderna 2nd dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Patient got 2nd dose of pfizer instead of Moderna 2nd dose) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Patient got 2nd dose of pfizer instead of Moderna 2nd dose). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Patient got 2nd dose of pfizer instead of Moderna 2nd dose) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient received the first dose of the Moderna COVID-19 approximately 28 days prior to receiving the Pfizer COVID-19 vaccine (date of vaccination for Pfizer not provided).   No concomitant medications were reported.  No treatment information was provided.